cache/a669f748e0d34fc76a3257ee0f2771637a96b7af604fca18c645a5656b18a301

COM:CORTERIAPHARMA

Corteria Pharma

  • Privately Held

Description

Corteria Pharma is a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological diseases. The company's lead product candidate is targeting Multiple Sclerosis (MS) with a potential best-in-class profile.

peer of

investor of

competitor of